TREANDA (Cephalon, Inc.)
Welcome to the PulseAid listing for the TREANDA drug offered from Cephalon, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cephalon, Inc. |
NON-PROPRIETARY NAME: | Bendamustine Hydrochloride |
SUBSTANCE NAME: | BENDAMUSTINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-01-05 |
END MARKETING DATE: | 0000-00-00 |
TREANDA HUMAN PRESCRIPTION DRUG Details:
Item Description | TREANDA from Cephalon, Inc. |
LABELER NAME: | Cephalon, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/5mL) |
START MARKETING DATE: | 2010-01-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63459-390_f0c07122-a1f6-43ab-820b-231864f51983 |
PRODUCT NDC: | 63459-390 |
APPLICATION NUMBER: | NDA022249 |
Other BENDAMUSTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: